Emerging Company Profile
Emmecell: magnetic cell therapy for eye diseases
Emmecell is slated to begin Phase I testing in corneal edema patients next year
Emmecell uses its magnetic nanoparticle platform to improve cell delivery, retention and integration in ophthalmic indications.
Emmecell emerged from stealth last week with a clinic-ready cell therapy for corneal edema that could address mild disease and offer a less invasive alternative